MRI changes and ApoE genotype, a prospective 1-year follow-up of traumatic brain injury: A pilot study

References

• Teasdale GM, Nicoll JA, Murray G, Fiddes M. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 1997; 350: 1069–1071
   PubMed Web of Science ®Google Scholar
• Sorbi S, Nacmias B, Piacentini S, et al. ApoE as a prognostic factor for posttraumatic coma. Nature Medicine 1995; 1: 852
   PubMed Web of Science ®Google Scholar
• Friedman G, Froom P, Sazbon L, et al. Apolipoprotein E-e4 genotype predicts a poor outcome in survivors of traumatic brain injury. Neurology 1999; 52: 244–248
   PubMed Web of Science ®Google Scholar
• Lichtman SW, Seliger G, Tycko B, Marder K. Apolipoprotein E and functional recovery from brain injury following postacute rehabilitation. Neurology 2000; 55: 1536–1539
   PubMed Web of Science ®Google Scholar
• Crawford FC, Vanderploeg RD, Freeman MJ, et al. APOE genotype influences acquisition and recall following traumatic brain injury. Neurology 2002; 58: 1115–1118
   PubMed Web of Science ®Google Scholar
• Teasdale GM, Murray GD, Nicoll JA. The association between APOE e4, age and outcome after head injury: A prospective cohort study. Brain 2005; 128: 2556–2561
   PubMed Web of Science ®Google Scholar
• Alexander S, Kerr ME, Kim Y, Kamboh MI, Beers SR, Conley YP. Apolipoprorein E4 allele presence and functional outcome after severe traumatic brain injury. Journal of Neurotrauma 2007; 24: 790–797
   PubMed Web of Science ®Google Scholar
• Graham DI, Horsburgh K, Nicoll JAR, et al. Apolipoprotein E and the response of the brain to injury. Acta Neurochirgica 1999; 73: 89–92
   Google Scholar
• Horsburgh K, McCarron MO, White F, Nicoll JA. The role of apolipoprotein E in Alzheimer's disease, acute brain injury and cerebrovascular disease: Evidence of common mechanisms and utility of animal models. Neurobiology of Aging 2000; 21: 245–255
   PubMed Web of Science ®Google Scholar
• Sabo T, Lomnitski L, Nyska A, et al. Susceptibility of transgenic mice expressing human apolipoprotein E to closed head injury: The allele E3 is neuroprotective whereas E4 increases fatalities. Neuroscience 2000; 101: 879–884
   PubMed Web of Science ®Google Scholar
• Millar K, Nicoll JA, Thornhill S, Murray GD, Teasdale GM. Long term neuropsychological outcome after head injury: Relation to APOE genotype. Journal of Neurology, Neurosurgery and Psychiatry 2003; 74: 1047–1052
   PubMed Web of Science ®Google Scholar
• Smith C, Graham DI, Murray LS, Stewart J, Nicoll JA. Association of APOE e4 and cerebrovascular pathology in traumatic brain injury. Journal of Neurology, Neurosurgery and Psychiatry 2006; 77: 363–366
   PubMed Web of Science ®Google Scholar
• Ariza M, Pueyo R, Matarin Mdel M, et al. Influence of APOE polymorphism on cognitive and behavioural outcome in moderate and severe traumatic brain injury. Journal of Neurology, Neurosurgery and Psychiatry 2006; 77: 1191–1193
   PubMed Web of Science ®Google Scholar
• Laskowitz DT, Sheng H, Bart RD, Joyner KA, Roses AD, Warner DS. Apolipoprotein E-deficient mice have increased susceptibility to focal cerebral ischemia. Journal of Cerebral Blood Flow Metabolism 1997; 17: 753–758
   PubMed Web of Science ®Google Scholar
• Poirier J, Baccichet A, Dea D, Gauthier S. Cholesterol synthesis and lipoprotein reuptake during synaptic remodeling in hippocampus in adult rats. Neuroscience 1993; 55: 81–90
   PubMed Web of Science ®Google Scholar
• Kay AD, Day SP, Kerr M, Nicoll JA, Packard CJ, Caslake MJ. Remodeling of cerebrospinal fluid lipoprotein particles after human traumatic brain injury. Journal of Neurotrauma 2003; 20: 717–723
   PubMedGoogle Scholar
• Nicoll JA, Roberts GW, Graham DI. Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury. Nature Medicine 1995; 1: 135–137
   PubMed Web of Science ®Google Scholar
• Graham DI, Gentleman SM, Nicoll AR, et al. Is there a genetic basis for the deposition of b-amyloid after fatal head injury?. Cell Molecular Neurobiology 1999; 19: 19–30
   PubMedGoogle Scholar
• Lee Y, Aono M, Laskowitz DT, Warner DS, Pearlstein RD. Apolipoprotein E protects against oxidative stress in mixed neuronal-glial cell cultures by reducing glutamate. Neurochemistry International 2004; 44: 107–118
   PubMed Web of Science ®Google Scholar
• Laskowitz DT, Goel B, Bennett ER, Matthew WD. Apolipoprotein E suppresses glial cell secretion of TNF alpha. Journal of Neuroimmunology 1997; 76: 70–74
   PubMed Web of Science ®Google Scholar
• Laskowitz DT, Mathews WD, Bennett BR, et al. Endogenous Apolipoprotein E suppresses LPS-stimulated microglial nitric oxide production. Neuro Report 1998; 9: 615–618
   PubMedGoogle Scholar
• Grocott HP, Newman MF, El Moalem H, Bainbridge D, Butler A, Laskowitz DT. Apolipoprotein E genotype differentially influences the proinflammatory and anti-inflammatory response to cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery 2001; 122: 622–623
   PubMed Web of Science ®Google Scholar
• Kerr ME, Kraus M, Marion D, Kamboh I. Evaluation of apolipoprotein E genotypes on cerebral blood flow, metabolism following traumatic brain injury. Oxygen transport to tissue XXI, A Eke, DT Delpy. Plenum Press, New York 1999; 117–124
   Google Scholar
• Strittmatter WJ, Saunders AM, Goedert M, et al. Isoform-spesific interactions of apolipoprotein E with microtubule -associated protein tau: Implications for Alzheimer disease. Proceedings if the National Academy of Sciences (USA) 1994; 91: 11183–11186
   PubMed Web of Science ®Google Scholar
• Bellosta S, Nathan BP, Orth M, Dong LM, Mahley RW, Pitas RE. Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. Journal of Biological Chemistry 1995; 270: 27063–27071
   PubMed Web of Science ®Google Scholar
• Fullerton SM, Shirman GA, Strittmatter WJ, Matthew WD. Impairment of the blood–nerve and blood–brain barriers in Apolipoprotein E knockout mice. Experimental Neurology 2001; 169: 13–22
   PubMed Web of Science ®Google Scholar
• Lynch JR, Pineda JA, Morgan D, et al. Apolipoprotein E affects the central nervous system response to injury and the development of cerebral edema. Annals of Neurology 2002; 51: 113–117
   PubMed Web of Science ®Google Scholar
• Ti LK, Mackensen GB, Grocott HP, et al. Apolipoprotein E4 increases aortic atheroma burden in cardiac surgical patients. Journal of Thoracic and Cardiovascular Surgery 3003; 125: 211–213
   Google Scholar
• Weir CJ, McCarron MO, Muir KW, et al. Apolipoprotein E genotype, coagulation, and survival following acute stroke. Neurology 2001; 57: 1097–1100
   PubMed Web of Science ®Google Scholar
• Rugg-Gunn FJ, Symms MR, Barker GJ, et al. Diffusion imaging shows abnormalities after blunt head trauma when conventional magnetic resonance imaging is normal. Journal of Neurology, Neurosurgery and Psychiatry 2001; 70: 530–533
   PubMed Web of Science ®Google Scholar
• MacKenzie JD, Siddiqi F, Babb JS, et al. Brain atrophy in mild or moderate traumatic brain injury: A longitudinal quantitative analysis. AJNR: American Journal of Neuroradiology 2002; 23: 1509–1515
   PubMed Web of Science ®Google Scholar
• Tomaiuolo F, Carlesimo GA, Di Paola M, et al. Gross morphology and morphometric sequelae in the hippocampus, fornix, and corpus callosum of patients with severe non-missile traumatic brain injury without macroscopically detectable lesions: a T1 weighted MRI study. Journal of Neurology, Neurosurgery and Psychiatry 2004; 75: 1314–1322
   PubMed Web of Science ®Google Scholar
• Arfanakis K, Haughton VM, Carew JD, et al. Diffusion tensor MR imaging in diffuse axonal injury. AJNR: American Journal of Neuroradiology 2002; 23: 794–802
   PubMed Web of Science ®Google Scholar
• Friedman SD, Brooks WM, Jung RE, et al. Quantitative proton MRS predicts outcome after traumatic brain injury. Neurology 1999; 52: 1384–1391
   PubMed Web of Science ®Google Scholar
• Son BC, Park CK, Choi BG, et al. Metabolic changes in pericontusional oedematous areas in mild head injury evaluated by1H MRS. Acta Neurochirgica 2000; 76(Suppl)13–16
   Google Scholar
• Assaf Y, Beit-Yannai E, Shohami E, Berman E, Cohen Y. Diffusion- and T2-weighted MRI of close-head injury in rats: A time course study and correlation with histology. Journal of Magnetic Resonance Imaging 1997; 15: 77–85
   Google Scholar
• Ezaki Y, Tsutsumi K, Morikawa M, Nagata I. Lesions identified on T2*-weighted gradient echo images in two patients with suspected diffuse axonal injury that resolved in less than ten days. Acta Neurochirgica (Wien) 2006; 148: 547–550
   PubMed Web of Science ®Google Scholar
• Jennett B, Bond M. Assessment of outcome after severe brain damage: A practical scale. Lancet 1975; i: 480–484
   Google Scholar
• King NS, Crawford S, Wenden FJ, et al. Measurement of post-traumatic amnesia: How reliable is it?. Journal of Neurology, Neurosurgery and Psychiatry 1997; 62: 38–42
   PubMed Web of Science ®Google Scholar
• McFarland K, Jackson L, Geffe G. Post-traumatic amnesia: Consistency-of-recovery and duration-to-recovery following traumatic brain impairment. Clinical Neuropsychology 2001; 15: 59–68
   PubMed Web of Science ®Google Scholar
• Kay T, Harrington DE, Adams R, et al. Definition of mild traumatic brain injury. Journal of Head Trauma Rehabilitation 1993; 8: 86–87
   Google Scholar
• Donohoe GG, Laaksonen M, Pulkki K, et al. Rapid single-tube screening of the C282Y hemochromatosis mutation by real-time multiplex allele-specific PCR without fluorescent probes. Clinical Chemistry 2000; 46: 1540–1547
   PubMed Web of Science ®Google Scholar
• Donohoe GG, Salomäki A, Lehtimäki T, et al. Rapid identification of apolipoprotein E genotypes by multiplex amplification refractory mutation system PCR and capillary gel electrophoresis. Clinical Chemistry 1999; 45: 143–146
   PubMed Web of Science ®Google Scholar
• Evans WA, Jr. An encephalographic ratio for estimating ventricular enlargement and cerebral atrophy. Archives of Neurology and Psychiatry 1942; 42: 931–937
   Google Scholar
• Scheltens P, Barkhof F, Leys D, et al. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. Journal of Neurological Science 1993; 114: 7–12
   PubMed Web of Science ®Google Scholar
• Ehnholm C, Lukka M, Kuusi T, Nikkilä E, Utermann G. Apolipoprotein E polymorphism in the Finnish population: Gene frequencies and relation to lipoprotein concentrations. Journal of Lipid Research 1986; 27: 227–235
   PubMed Web of Science ®Google Scholar
• Mauch DH, Nagler K, Schumacher S, et al. CNS synaptogenesis promoted by glia-derivated cholesterol. Science 2001; 294: 1354–1357
   PubMed Web of Science ®Google Scholar
• White F, Nicoll JA, Roses AD, Horsburgh K. Impaired neuronal plasticity in transgenic mice expressing human apolipoprotein E4 compared to E3 in a model of entorhinal cortex lesion. Neurobiology of Disease 2001; 8: 611–625
   PubMed Web of Science ®Google Scholar
• Lynch JR, Tang W, Wang H, et al. APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response. Journal of Biological Chemistry 2003; 278: 48529–48533
   PubMed Web of Science ®Google Scholar
• Laskowitz DT, Thekdi AD, Thekdi SD, et al. Downregulation of microglial activation by apolipoprotein E and apoE-mimetic peptides. Experimental Neurology 2001; 167: 74–85
   PubMed Web of Science ®Google Scholar
• Heesen C, Nawrath L, Reich C, Bauer N, Schulz KH, Gold SM. Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?. Journal of Neurology, Neurosurgery and Psychiatry 2006; 77: 34–39
   PubMed Web of Science ®Google Scholar
• Sundström A, Nilsson LG, Cruts M, Adolfsson R, Van Broeckhoeven C, Nyberg L. Fatigue before and after mild traumatic brain injury: pre–post-injury comparisons in relation to Apolipoprotein E. Brain Injury 2007; 21: 1049–1054
   PubMed Web of Science ®Google Scholar
• Mui S, Briggs M, Chung H, et al. A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with Alzheimer's disease and strongly with epsilon 4 allele. Neurology 1996; 47: 196–201
   PubMedGoogle Scholar
• Lambert JC, Pasquier F, Cottel D, et al. A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease. Human Molecular Genetics 1998; 7: 533–540
   PubMedGoogle Scholar
• Artiga MJ, Bullido MJ, Frank A, et al. Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. FEBS Letters 1998; 421: 105–108
   PubMedGoogle Scholar
• Bullido MJ, Artiga MJ, Recuero M, et al. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nature of Genetics 1998; 18: 69–71
   PubMed Web of Science ®Google Scholar
• Lambert JC, Berr C, Pasquier F, et al. Pronounced impact of Th1/E47 cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. Human Molecular Genetics 1998; 7: 1511–1516
   PubMedGoogle Scholar
• Lambert JC, Brousseau T, Defosse V, et al. Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations—the ECTIM study. Human Molecular Genetics 2000; 9: 57–61
   PubMed Web of Science ®Google Scholar
• Roks G, Cruts M, Houwing-Duistermaat JJ, et al. Effect of the APOE-491A/T promoter polymorphism on apolipoprotein E levels and risk of Alzheimer disease: The Rotterdam study. American Journal of Medical Genetics 2002; 114: 570–573
   PubMedGoogle Scholar
• Laws SM, Taddei K, Martins G, et al. The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease. Neuroreport 1999; 10: 879–882
   PubMedGoogle Scholar
• Laws SM, Taddei K, Martins G, et al. Variation at the APOE-491 promoter locus is associated with altered brain levels of apolipoprotein E. Molecular Psychiatry 2002; 7: 886–890
   PubMedGoogle Scholar
• Lambert JC, Araria-Goumidi L, Myllykangas L, et al. Contribution of APOE promoter polymorphisms to Alzheimer's disease risk. Neurology 2002; 59: 59–66
   PubMedGoogle Scholar
• Heijmans BT, Slagboom PE, Gussekloo J, et al. Association of APOE epsilon2/epsilon3/epsilon 4 and promoter gene variants with dementia but not cardiovascular mortality in old age. American Journal of Medical Genetics 2002; 107: 201–208
   PubMedGoogle Scholar
• Lambert JC, Mann D, Goumidi L, et al. Effect of the APOE promoter polymorphisms on cerebral amyloid peptide deposition in Alzheimer's disease. Lancet 2001; 357: 608–609
   PubMed Web of Science ®Google Scholar
• Berr C, Lambert JC, Sazdovitch V, et al. Neuropathological epidemiology of cerebral aging: A study of two genetic polymorphisms. Neurobiology of Aging 2001; 22: 227–235
   PubMedGoogle Scholar
• Myllykangas L, Polvikoski T, Reunanen K, et al. ApoE epsilon 3-haplotype modulates Alzheimer beta-amyloid deposition in the brain. American Journal of Medical Genetics 2002; 114: 288–291
   PubMedGoogle Scholar
• Pankhe J, Walker LC, Schroeder E, et al. Cerebral beta-amyloid deposition is augmented by the -491 AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele. Acta Neuropathologica 2003; 105: 25–29
   PubMedGoogle Scholar
• Teter B. ApoE-dependent plasticity in Alzheimer's disease. Journal of Molecular Neuroscience 2004; 23: 167–179
   PubMed Web of Science ®Google Scholar
• Brandstack N, Kurki T, Tenovuo O, Isoniemi H. MR imaging of head trauma: Visibility of contusions and other intraparenchymal injuries in early and late stage. Brain Injury 2006; 20: 409–416
   PubMed Web of Science ®Google Scholar
• Isoniemi H, Kurki T, Tenovuo O, Kairisto V, Portin R. Hippocampal volume, brain atrophy, and APOE genotype after traumatic brain injury. Neurology 2006; 67: 756–760
   PubMed Web of Science ®Google Scholar